VANGUARD GROUP INC - 30 Sep 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock (NKTR)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Nektar Therapeutics Common Stock
Symbol: NKTR
Shares outstanding: 19,049,137 shares
Disclosed Ownership: 948,647 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 31 Oct 2025, 11:05:02 UTC
Date of event: 30 Sep 2025
Next filing: 30 Jan 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5%	948,647	0	106,881	Ashley Grim	Head of Global Fund Administration